CSIMarket



Best Performing Stocks In Medical Equipment & Supplies Industry During The Last 5 Days



 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 
 

Shares are up by 2.6% on average, in Medical Equipment & Supplies Industry during the last 5 days.

Here are the best performing stocks in Medical Equipment & Supplies Industry.




FRES

$2.96

$2.6142 755.99%
Last 5 Days


FRES

$2.96

$2.6142 755.99%



Prolung Inc

Prolung Inc stock improved 755.99% during the last 5 days.


Prolung Inc operates on a business model that focuses on developing and commercializing innovative medical devices for the diagnosis and treatment of respiratory conditions. Their approach involves extensive research and development, strategic partnerships and collaborations, as well as sales and distribution channels to reach and serve the market effectively.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 13.594 mill. $ - mill. $ -3.407 mill. 5 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 13.594 mill.


$ - mill.


$ -3.407 mill.

Employees Shares Outstanding P/E

-


5 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



MLSS

$1.01

$0.3511 53.29%
Last 5 Days


MLSS

$1.01

$0.3511 53.29%



Milestone Scientific Inc

Milestone Scientific Inc shares increased 53.29% during the last 5 days.


Milestone Scientific Inc*s business model focuses on developing and commercializing innovative medical devices and instruments, particularly in the field of drug delivery. Their products strive to enhance patient comfort and improve clinical outcomes through precision and ease of use.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 80.536 mill. $ 9.444 mill. $ -7.102 mill. 80 mill. - Y/Y -13.43 %
Market Cap. Revenues TTM Net Income TTM

$ 80.536 mill.


$ 9.444 mill.


$ -7.102 mill.

Employees Shares Outstanding P/E

-


80 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -13.43 %


MRQ Y/Y - %



CLPT

$7.52

$1.8900 33.57%
Last 5 Days


CLPT

$7.52

$1.8900 33.57%



Clearpoint Neuro Inc

Clearpoint Neuro Inc shares improved 33.57% during the last 5 days.


Clearpoint Neuro Inc*s business model revolves around providing advanced deep brain stimulation (DBS) solutions for the treatment of neurological disorders. It focuses on developing and commercializing innovative medical devices, software, and services that enable precise and accurate targeting for electrode placement during neurosurgical procedures.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 191.400 mill. $ 26.161 mill. $ -20.626 mill. 25 mill. - Y/Y 40.60 %
Market Cap. Revenues TTM Net Income TTM

$ 191.400 mill.


$ 26.161 mill.


$ -20.626 mill.

Employees Shares Outstanding P/E

-


25 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 40.60 %


MRQ Y/Y - %



INO

$11.31

$2.6300 30.30%
Last 5 Days


INO

$11.31

$2.6300 30.30%



Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc shares increased 30.30% during the last 5 days.


Inovio Pharmaceuticals Inc is a biotechnology company that focuses on the development and commercialization of immunotherapies for the treatment of various diseases, including cancers and infectious diseases. Their business model involves leveraging their proprietary platforms, such as DNA-based technology and electroporation, to design and develop novel vaccines and therapies which are then advanced through clinical trials and potential partnerships for further commercialization.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 263.427 mill. $ 8.143 mill. $ -124.938 mill. 23 mill. - Y/Y -35.39 %
Market Cap. Revenues TTM Net Income TTM

$ 263.427 mill.


$ 8.143 mill.


$ -124.938 mill.

Employees Shares Outstanding P/E

-


23 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -35.39 %


MRQ Y/Y - %



DRIO

$1.43

$0.3000 26.55%
Last 5 Days


DRIO

$1.43

$0.3000 26.55%



Dariohealth Corp

Dariohealth Corp shares improved 26.55% during the last 5 days.


DarioHealth Corp*s business model revolves around providing digital health solutions to individuals with chronic diseases. Through their mobile health platform, they offer personalized tools and remote monitoring capabilities that empower patients to proactively manage their conditions. By combining software, data analytics, and medical devices, DarioHealth aims to enhance patient engagement, improve health outcomes, and reduce healthcare costs.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 49.253 mill. $ 18.350 mill. $ 53.777 mill. 34 mill. 0.85 Y/Y -23.12 %
Market Cap. Revenues TTM Net Income TTM

$ 49.253 mill.


$ 18.350 mill.


$ 53.777 mill.

Employees Shares Outstanding P/E

-


34 mill.


0.85

Revenue Growth Income Growth

MRQ Y/Y -23.12 %


MRQ Y/Y -44.05 %



TMCI

$8.12

$1.4600 21.92%
Last 5 Days


TMCI

$8.12

$1.4600 21.92%



Treace Medical Concepts Inc

Treace Medical Concepts Inc shares improved 21.92% during the last 5 days.


Treace Medical Concepts Inc offers innovative surgical solutions primarily for foot and ankle disorders.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 499.887 mill. $ 153.618 mill. $ -62.723 mill. 62 mill. - Y/Y 23.30 %
Market Cap. Revenues TTM Net Income TTM

$ 499.887 mill.


$ 153.618 mill.


$ -62.723 mill.

Employees Shares Outstanding P/E

-


62 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 23.30 %


MRQ Y/Y - %



PSTV

$1.82

$0.3200 21.33%
Last 5 Days


PSTV

$1.82

$0.3200 21.33%



Plus Therapeutics Inc

Plus Therapeutics Inc shares improved 21.33% during the last 5 days.


Plus Therapeutics Inc is a biotechnology company that focuses on developing precision nanoparticles for targeted therapy. They utilize their proprietary technology to create and commercialize innovative drugs for the treatment of cancer and other diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 5.870 mill. $ 3.751 mill. $ -15.164 mill. 3 mill. - Y/Y 1,598.63 %
Market Cap. Revenues TTM Net Income TTM

$ 5.870 mill.


$ 3.751 mill.


$ -15.164 mill.

Employees Shares Outstanding P/E

-


3 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 1,598.63 %


MRQ Y/Y - %



CTCX

$1.83

$0.3100 20.39%
Last 5 Days


CTCX

$1.83

$0.3100 20.39%



Carmell Corporation

Carmell Corporation shares improved 20.39% during the last 5 days.


Carmell Corporation operates on a B2B model, providing customized software solutions for businesses across various industries, along with ongoing support and maintenance services to ensure their software is efficient and up-to-date. They focus on understanding individual business needs and delivering tailored solutions to help optimize their clients* operations and maximize their productivity.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 34.092 mill. $ 3.185 mill. $ -10.332 mill. 19 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 34.092 mill.


$ 3.185 mill.


$ -10.332 mill.

Employees Shares Outstanding P/E

-


19 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NVNO

$5.99

$1.0100 20.28%
Last 5 Days


NVNO

$5.99

$1.0100 20.28%



Envveno Medical Corporation

Envveno Medical Corporation stock went up 20.28% during the last 5 days.


Envveno Medical Corporation is a medical technology company that focuses on developing and manufacturing innovative healthcare products. Their business model involves conducting extensive research and development to create cutting-edge medical solutions, collaborating with healthcare professionals and institutions to ensure effective implementation, and commercializing their products through strategic partnerships and distribution networks worldwide. By providing advanced medical technologies, Envveno Medical aims to improve patient outcomes and enhance the overall healthcare experience.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 96.181 mill. $ - mill. $ -22.411 mill. 16 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 96.181 mill.


$ - mill.


$ -22.411 mill.

Employees Shares Outstanding P/E

-


16 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



VVOS

$2.81

$0.4650 19.83%
Last 5 Days


VVOS

$2.81

$0.4650 19.83%



Vivos Therapeutics Inc

Vivos Therapeutics Inc stock improved 19.83% during the last 5 days.


Vivos Therapeutics Inc employs a business model that focuses on providing innovative solutions for the treatment of breathing-related sleep disorders.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 6.486 mill. $ 12.351 mill. $ -15.643 mill. 2 mill. - Y/Y -23.85 %
Market Cap. Revenues TTM Net Income TTM

$ 6.486 mill.


$ 12.351 mill.


$ -15.643 mill.

Employees Shares Outstanding P/E

-


2 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -23.85 %


MRQ Y/Y - %



PLSE

$18.58

$3.0700 19.79%
Last 5 Days


PLSE

$18.58

$3.0700 19.79%



Pulse Biosciences Inc

Pulse Biosciences Inc stock improved 19.79% during the last 5 days.


Pulse Biosciences Inc*s business model focuses on the development and commercialization of proprietary technology platforms, specifically in the field of nano-pulse stimulation (NPS) technology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,025.096 mill. $ - mill. $ -42.546 mill. 55 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1,025.096 mill.


$ - mill.


$ -42.546 mill.

Employees Shares Outstanding P/E

-


55 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



SGHT

$7.61

$1.2100 18.91%
Last 5 Days


SGHT

$7.61

$1.2100 18.91%



Sight Sciences Inc

Sight Sciences Inc shares increased 18.91% during the last 5 days.


Sight Sciences Inc operates using a business model focused on developing and commercializing innovative medical devices and technologies for the treatment of ophthalmic diseases. They aim to improve patient outcomes and provide value to healthcare providers by constantly advancing their product portfolio and expanding their reach in the ophthalmology market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 370.387 mill. $ 81.790 mill. $ -61.763 mill. 49 mill. - Y/Y 3.51 %
Market Cap. Revenues TTM Net Income TTM

$ 370.387 mill.


$ 81.790 mill.


$ -61.763 mill.

Employees Shares Outstanding P/E

-


49 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 3.51 %


MRQ Y/Y - %



CATX

$12.91

$1.9500 17.79%
Last 5 Days


CATX

$12.91

$1.9500 17.79%



Perspective Therapeutics Inc

Perspective Therapeutics Inc shares improved 17.79% during the last 5 days.


Perspective Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative therapeutic solutions. Their business model involves conducting extensive research and development to create novel drug candidates targeting specific diseases. They aim to collaborate with pharmaceutical companies and seek partnerships to further develop and commercialize their products, ultimately making a positive impact on patients* lives.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3,531.872 mill. $ - mill. $ 2.651 mill. 274 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 3,531.872 mill.


$ - mill.


$ 2.651 mill.

Employees Shares Outstanding P/E

-


274 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



BEAT

$3.1

$0.4600 17.42%
Last 5 Days


BEAT

$3.1

$0.4600 17.42%



Heartbeam Inc

Heartbeam Inc shares improved 17.42% during the last 5 days.


Heartbeam Inc*s business model is focused on providing innovative solutions and services related to heart health and medical technology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 82.185 mill. $ - mill. $ -15.109 mill. 27 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 82.185 mill.


$ - mill.


$ -15.109 mill.

Employees Shares Outstanding P/E

-


27 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



STVN

$21.71

$3.1700 17.10%
Last 5 Days


STVN

$21.71

$3.1700 17.10%



Stevanato Group S p a

Stevanato Group S P A shares increased 17.10% during the last 5 days.


Stevanato Group S.p.a is a global provider of packaging and drug delivery solutions for the pharmaceutical industry. The company specializes in the design and manufacturing of glass containers, syringes, cartridges, and other primary packaging components. They also offer comprehensive services including drug delivery devices and analytical testing, ensuring end-to-end support for pharmaceutical companies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 5,743.059 mill. $ 1,101.722 mill. $ 160.178 mill. 265 mill. 35.90 Y/Y 0.00 %
Market Cap. Revenues TTM Net Income TTM

$ 5,743.059 mill.


$ 1,101.722 mill.


$ 160.178 mill.

Employees Shares Outstanding P/E

-


265 mill.


35.90

Revenue Growth Income Growth

MRQ Y/Y 0.00 %


MRQ Y/Y 0.00 %



OM

$4.2

$0.6100 16.99%
Last 5 Days


OM

$4.2

$0.6100 16.99%



Outset Medical Inc

Outset Medical Inc shares improved 16.99% during the last 5 days.


Outset Medical Inc*s business model revolves around the production and distribution of innovative medical devices for kidney dialysis. With a focus on patient-centric care, their flagship product Tablo simplifies dialysis and allows for it to be performed in various clinical settings, including hospitals, clinics, and homes. By offering a comprehensive solution that combines hardware, software, and support services, Outset Medical aims to improve the dialysis experience for both healthcare providers and patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 208.555 mill. $ 131.334 mill. $ -175.641 mill. 50 mill. - Y/Y 8.63 %
Market Cap. Revenues TTM Net Income TTM

$ 208.555 mill.


$ 131.334 mill.


$ -175.641 mill.

Employees Shares Outstanding P/E

500


50 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 8.63 %


MRQ Y/Y - %



WGS

$32.8

$4.7000 16.73%
Last 5 Days


WGS

$32.8

$4.7000 16.73%



Genedx Holdings Corp

Genedx Holdings Corp stock went up 16.73% during the last 5 days.


Genedx Holdings Corp operates as a genetic testing company, offering molecular and biochemical testing services for various genetic disorders and diseases. The company generates revenue by providing testing services to medical professionals and institutions around the world, aiding in accurate diagnosis and treatment planning for patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 854.839 mill. $ 221.278 mill. $ -135.017 mill. 26 mill. - Y/Y 44.67 %
Market Cap. Revenues TTM Net Income TTM

$ 854.839 mill.


$ 221.278 mill.


$ -135.017 mill.

Employees Shares Outstanding P/E

-


26 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 44.67 %


MRQ Y/Y - %



MOVE

$0.379

$0.0540 16.62%
Last 5 Days


MOVE

$0.379

$0.0540 16.62%



Movano Inc

Movano Inc shares increased 16.62% during the last 5 days.


a Delaware corporation, is developing a platform to deliver purpose-driven healthcare solutions at the intersection of medtech and consumer devices


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 19.220 mill. $ - mill. $ -31.252 mill. 51 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 19.220 mill.


$ - mill.


$ -31.252 mill.

Employees Shares Outstanding P/E

27


51 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



TELA

$5.04

$0.7100 16.40%
Last 5 Days


TELA

$5.04

$0.7100 16.40%



Tela Bio Inc

Tela Bio Inc shares improved 16.40% during the last 5 days.


Tela Bio Inc is a company that operates on a business model centered around developing and commercializing novel medical products for soft tissue repair and reconstruction.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 123.880 mill. $ 61.634 mill. $ -40.298 mill. 25 mill. - Y/Y 38.28 %
Market Cap. Revenues TTM Net Income TTM

$ 123.880 mill.


$ 61.634 mill.


$ -40.298 mill.

Employees Shares Outstanding P/E

-


25 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 38.28 %


MRQ Y/Y - %



AMIX

$0.618

$0.0860 16.17%
Last 5 Days


AMIX

$0.618

$0.0860 16.17%



Autonomix Medical Inc

Autonomix Medical Inc stock went up 16.17% during the last 5 days.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 9.079 mill. $ - mill. $ -26.216 mill. 15 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 9.079 mill.


$ - mill.


$ -26.216 mill.

Employees Shares Outstanding P/E

-


15 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



STRR

$4.703

$0.6530 16.12%
Last 5 Days


STRR

$4.703

$0.6530 16.12%



Star Equity Holdings Inc

Star Equity Holdings Inc stock improved 16.12% during the last 5 days.


Star Equity Holdings Inc is a company that operates with a business model focused on equity investments. They primarily invest in a diverse range of businesses across different industries to generate substantial returns for their shareholders. By carefully selecting investments and actively managing their portfolio, they aim to maximize profitability and create long-term value for their stakeholders.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 74.505 mill. $ 29.198 mill. $ 22.473 mill. 16 mill. 3.46 Y/Y -64.53 %
Market Cap. Revenues TTM Net Income TTM

$ 74.505 mill.


$ 29.198 mill.


$ 22.473 mill.

Employees Shares Outstanding P/E

-


16 mill.


3.46

Revenue Growth Income Growth

MRQ Y/Y -64.53 %


MRQ Y/Y - %



LUNG

$7.42

$0.9700 15.04%
Last 5 Days


LUNG

$7.42

$0.9700 15.04%



Pulmonx Corporation

Pulmonx Corporation shares went up 15.04% during the last 5 days.


Pulmonx Corporation is a medical device company that specializes in the development and commercialization of minimally-invasive treatments for patients with severe emphysema. Their business model revolves around providing advanced solutions to physicians and healthcare facilities to improve patient outcomes and quality of life. The company focuses on developing and marketing innovative technologies, such as the Zephyr Valve System, which aim to address the unmet needs of patients suffering from severe emphysema.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 286.679 mill. $ 71.295 mill. $ -58.732 mill. 39 mill. - Y/Y 24.38 %
Market Cap. Revenues TTM Net Income TTM

$ 286.679 mill.


$ 71.295 mill.


$ -58.732 mill.

Employees Shares Outstanding P/E

-


39 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 24.38 %


MRQ Y/Y - %



BTCY

$0.885

$0.1150 14.94%
Last 5 Days


BTCY

$0.885

$0.1150 14.94%



Biotricity Inc

Biotricity Inc stock improved 14.94% during the last 5 days.


The business model of Biotricity Inc focuses on providing medical technology solutions through the development and commercialization of innovative biomedical devices and services. The company leverages its expertise in remote patient monitoring, data analytics, and artificial intelligence to deliver personalized healthcare solutions to both patients and healthcare professionals. Biotricity Inc aims to improve patient outcomes, reduce healthcare costs, and enhance the overall efficiency of the healthcare system.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 7.959 mill. $ 11.640 mill. $ -14.249 mill. 9 mill. - Y/Y 22.29 %
Market Cap. Revenues TTM Net Income TTM

$ 7.959 mill.


$ 11.640 mill.


$ -14.249 mill.

Employees Shares Outstanding P/E

-


9 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 22.29 %


MRQ Y/Y - %



SINT

$5.17

$0.6400 14.13%
Last 5 Days


SINT

$5.17

$0.6400 14.13%



Sintx Technologies Inc

Sintx Technologies Inc shares increased 14.13% during the last 5 days.


Sintx Technologies Inc is a company that operates under a business model focused on developing and commercializing silicon nitride-based ceramics for various applications.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 178.163 mill. $ 2.775 mill. $ -8.852 mill. 34 mill. - Y/Y 27.46 %
Market Cap. Revenues TTM Net Income TTM

$ 178.163 mill.


$ 2.775 mill.


$ -8.852 mill.

Employees Shares Outstanding P/E

-


34 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 27.46 %


MRQ Y/Y - %



SIBN

$15.32

$1.8300 13.57%
Last 5 Days


SIBN

$15.32

$1.8300 13.57%



Si bone inc

Si Bone Inc shares went up 13.57% during the last 5 days.


SiBone Inc*s business model revolves around the development and commercialization of innovative medical devices for the treatment of musculoskeletal disorders, particularly focused on the utilization of their patented iFuse Implant System.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 627.115 mill. $ 143.577 mill. $ -43.115 mill. 41 mill. - Y/Y 15.77 %
Market Cap. Revenues TTM Net Income TTM

$ 627.115 mill.


$ 143.577 mill.


$ -43.115 mill.

Employees Shares Outstanding P/E

-


41 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 15.77 %


MRQ Y/Y - %



NUWE

$4.5

$0.5200 13.07%
Last 5 Days


NUWE

$4.5

$0.5200 13.07%



Nuwellis Inc

Nuwellis Inc shares went up 13.07% during the last 5 days.


Nuwellis Inc.*s business model revolves around developing and commercializing innovative therapeutic solutions, predominantly focusing on fluid management to improve outcomes for patients with critical illnesses. They aim to provide advanced medical devices and solutions to healthcare professionals, addressing the pressing need for better fluid management in critical care settings.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 28.288 mill. $ 8.014 mill. $ -17.093 mill. 6 mill. - Y/Y 1.70 %
Market Cap. Revenues TTM Net Income TTM

$ 28.288 mill.


$ 8.014 mill.


$ -17.093 mill.

Employees Shares Outstanding P/E

-


6 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 1.70 %


MRQ Y/Y - %



RCEL

$9.36

$1.0700 12.91%
Last 5 Days


RCEL

$9.36

$1.0700 12.91%



Avita Medical Inc

Avita Medical Inc shares improved 12.91% during the last 5 days.


Avita Medical Inc is a medical technology company that specializes in regenerative medicine. Their business model focuses on developing and commercializing innovative products for the treatment of burns, chronic wounds, and other skin-related conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 237.760 mill. $ 45.403 mill. $ -33.669 mill. 25 mill. - Y/Y 50.08 %
Market Cap. Revenues TTM Net Income TTM

$ 237.760 mill.


$ 45.403 mill.


$ -33.669 mill.

Employees Shares Outstanding P/E

-


25 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 50.08 %


MRQ Y/Y - %



NEPH

$2.29

$0.2600 12.81%
Last 5 Days


NEPH

$2.29

$0.2600 12.81%



Nephros Inc

Nephros Inc shares improved 12.81% during the last 5 days.


Nephros Inc operates under a business model focused on developing and marketing specialty medical products and technologies for renal disease patients. The company aims to provide innovative filtration and purification solutions to improve the quality of life for individuals with renal disorders.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 24.045 mill. $ 13.405 mill. $ -1.575 mill. 11 mill. - Y/Y 67.97 %
Market Cap. Revenues TTM Net Income TTM

$ 24.045 mill.


$ 13.405 mill.


$ -1.575 mill.

Employees Shares Outstanding P/E

-


11 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 67.97 %


MRQ Y/Y - %



MYO

$4.59

$0.5200 12.78%
Last 5 Days


MYO

$4.59

$0.5200 12.78%



Myomo Inc

Myomo Inc shares went up 12.78% during the last 5 days.


Myomo Inc*s business model revolves around the development and commercialization of advanced medical devices, specifically myoelectric orthotics for individuals with neuromuscular disorders.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 161.873 mill. $ 17.258 mill. $ -7.855 mill. 35 mill. - Y/Y 13.12 %
Market Cap. Revenues TTM Net Income TTM

$ 161.873 mill.


$ 17.258 mill.


$ -7.855 mill.

Employees Shares Outstanding P/E

-


35 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 13.12 %


MRQ Y/Y - %



ARAY

$1.97

$0.2200 12.57%
Last 5 Days


ARAY

$1.97

$0.2200 12.57%



Accuray Incorporated

Accuray Incorporated shares increased 12.57% during the last 5 days.


Accuray Incorporated is a medical technology company that focuses on the development and sale of radiation therapy systems. Their business model revolves around providing advanced and precise treatment options to cancer patients by combining robotics and imaging technologies. By delivering innovative solutions, Accuray aims to improve patient outcomes and establish partnerships with healthcare providers worldwide.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 190.213 mill. $ 454.284 mill. $ -11.203 mill. 97 mill. - Y/Y -5.94 %
Market Cap. Revenues TTM Net Income TTM

$ 190.213 mill.


$ 454.284 mill.


$ -11.203 mill.

Employees Shares Outstanding P/E

1,000


97 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -5.94 %


MRQ Y/Y - %



TTOO

$5.49

$0.6100 12.50%
Last 5 Days


TTOO

$5.49

$0.6100 12.50%



T2 Biosystems Inc

T2 Biosystems Inc stock increased 12.50% during the last 5 days.


T2 Biosystems Inc operates on a business model centered around developing and commercializing innovative diagnostic solutions for medical purposes. Their technology relies on magnetic resonance for the detection of pathogens, toxins, and other molecules associated with various diseases. By offering rapid, accurate, and portable diagnostic capabilities, T2 Biosystems aims to improve patient outcomes and facilitate appropriate treatment decisions in healthcare settings.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 24.580 mill. $ 10.997 mill. $ -49.836 mill. 4 mill. - Y/Y -59.97 %
Market Cap. Revenues TTM Net Income TTM

$ 24.580 mill.


$ 10.997 mill.


$ -49.836 mill.

Employees Shares Outstanding P/E

-


4 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -59.97 %


MRQ Y/Y - %



SLNO

$47.67

$5.2600 12.40%
Last 5 Days


SLNO

$47.67

$5.2600 12.40%



Soleno Therapeutics Inc

Soleno Therapeutics Inc shares increased 12.40% during the last 5 days.


Soleno Therapeutics Inc*s business model focuses on the development and commercialization of innovative therapeutics for rare diseases. They aim to identify and address unmet medical needs in the market by conducting clinical trials and seeking regulatory approval for their investigational drugs. The company is committed to advancing its portfolio of therapeutics and establishing strategic partnerships to enhance its product development and commercialization efforts.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 545.190 mill. $ - mill. $ -33.178 mill. 11 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 545.190 mill.


$ - mill.


$ -33.178 mill.

Employees Shares Outstanding P/E

-


11 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NVCR

$17.98

$1.9800 12.38%
Last 5 Days


NVCR

$17.98

$1.9800 12.38%



Novocure Limited

Novocure Limited stock improved 12.38% during the last 5 days.


Novocure Limited is a medical technology company that focuses on developing and commercializing innovative therapies for cancer treatment. The company*s business model revolves around its proprietary treatment platform called tumor treating fields (TTFields), which uses electric fields to disrupt cancer cell division and inhibit tumor growth. Novocure operates by manufacturing and distributing its TTFields delivery system, while also conducting clinical trials and collaborating with healthcare providers to integrate its therapy into standard cancer care.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,928.646 mill. $ 525.659 mill. $ -192.742 mill. 107 mill. - Y/Y 13.36 %
Market Cap. Revenues TTM Net Income TTM

$ 1,928.646 mill.


$ 525.659 mill.


$ -192.742 mill.

Employees Shares Outstanding P/E

1,000


107 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 13.36 %


MRQ Y/Y - %



EMBC

$13.17

$1.4300 12.18%
Last 5 Days


EMBC

$13.17

$1.4300 12.18%



Embecta Corp

Embecta Corp stock went up 12.18% during the last 5 days.


Embecta Corp is a company that operates on a business-to-business (B2B) model, providing services or products to other businesses rather than individual consumers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 761.226 mill. $ 1,130.400 mill. $ 70.200 mill. 58 mill. 10.85 Y/Y 3.36 %
Market Cap. Revenues TTM Net Income TTM

$ 761.226 mill.


$ 1,130.400 mill.


$ 70.200 mill.

Employees Shares Outstanding P/E

-


58 mill.


10.85

Revenue Growth Income Growth

MRQ Y/Y 3.36 %


MRQ Y/Y 106.43 %



OFIX

$15.77

$1.6300 11.53%
Last 5 Days


OFIX

$15.77

$1.6300 11.53%



Orthofix Medical Inc

Orthofix Medical Inc stock went up 11.53% during the last 5 days.


Orthofix Medical Inc is a company that focuses on developing and selling medical devices and orthopedic solutions to healthcare providers and patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 591.006 mill. $ 667.747 mill. $ -136.283 mill. 37 mill. - Y/Y 61.20 %
Market Cap. Revenues TTM Net Income TTM

$ 591.006 mill.


$ 667.747 mill.


$ -136.283 mill.

Employees Shares Outstanding P/E

1,000


37 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 61.20 %


MRQ Y/Y - %



NMTC

$0.95

$0.0961 11.25%
Last 5 Days


NMTC

$0.95

$0.0961 11.25%



Neuroone Medical Technologies Corporation

Neuroone Medical Technologies Corporation shares went up 11.25% during the last 5 days.


Neuroone Medical Technologies Corp operates using a specific business model that focuses on delivering medical solutions or technologies related to neurological disorders or conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 22.796 mill. $ 2.816 mill. $ -13.472 mill. 24 mill. - Y/Y 753.25 %
Market Cap. Revenues TTM Net Income TTM

$ 22.796 mill.


$ 2.816 mill.


$ -13.472 mill.

Employees Shares Outstanding P/E

1


24 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 753.25 %


MRQ Y/Y - %



FNA

$7.58

$0.7200 10.50%
Last 5 Days


FNA

$7.58

$0.7200 10.50%



Paragon 28 Inc

Paragon 28 Inc stock improved 10.50% during the last 5 days.


Paragon 28 Inc has a business model focused on designing, manufacturing, and distributing innovative orthopedic medical devices to meet the specific needs of foot and ankle surgeons.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 625.721 mill. $ 206.942 mill. $ -67.045 mill. 83 mill. - Y/Y 13.87 %
Market Cap. Revenues TTM Net Income TTM

$ 625.721 mill.


$ 206.942 mill.


$ -67.045 mill.

Employees Shares Outstanding P/E

201


83 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 13.87 %


MRQ Y/Y - %



DHAI

$3.5

$0.3300 10.41%
Last 5 Days


DHAI

$3.5

$0.3300 10.41%



Dih Holding Us Inc

Dih Holding Us Inc shares went up 10.41% during the last 5 days.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 44.814 mill. $ - mill. $ 0.640 mill. 13 mill. 56.65 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 44.814 mill.


$ - mill.


$ 0.640 mill.

Employees Shares Outstanding P/E

-


13 mill.


56.65

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y -71.50 %



LNSR

$4.88

$0.4600 10.41%
Last 5 Days


LNSR

$4.88

$0.4600 10.41%



Lensar Inc

Lensar Inc stock went up 10.41% during the last 5 days.


Lensar Inc is a medical technology company that operates through a business model focused on the development and commercialization of advanced laser systems for ophthalmic procedures. They aim to provide innovative solutions to healthcare professionals in order to enhance precision, safety, and efficiency in eye surgeries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 58.345 mill. $ 40.291 mill. $ -12.947 mill. 12 mill. - Y/Y 26.42 %
Market Cap. Revenues TTM Net Income TTM

$ 58.345 mill.


$ 40.291 mill.


$ -12.947 mill.

Employees Shares Outstanding P/E

-


12 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 26.42 %


MRQ Y/Y - %



CERS

$2.15

$0.1900 9.69%
Last 5 Days


CERS

$2.15

$0.1900 9.69%



Cerus Corporation

Cerus Corporation stock improved 9.69% during the last 5 days.


Cerus Corporation*s business model revolves around developing and commercializing innovative technologies and products for the enhancement of blood safety.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 389.017 mill. $ 214.720 mill. $ -49.883 mill. 181 mill. - Y/Y -36.86 %
Market Cap. Revenues TTM Net Income TTM

$ 389.017 mill.


$ 214.720 mill.


$ -49.883 mill.

Employees Shares Outstanding P/E

309


181 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -36.86 %


MRQ Y/Y - %




 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com